This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Summit At ChinaBio Partnering Forum
Shanghai, China
Kerry Hotel Pudong, Shanghai, ChinaApril 28–29, 2026
Book Now
Menu
Book

Feifei Liang
Senior Vice President/R&D leader at EdiGene Inc.
Speaker

Profile

PhD in Cell & Oncology (Université Paris-Sud/CNRS), spearheads translational cell therapy development. Pioneered CAR-T therapies process and manufacturing targeting hematologic malignancies and solid tumours at Legend Biotech. Established EdiGene’s Allogeneic immune Cell R&D Platform and directed IND-enabling studies, accelerating oncology and autoimmune FIH trials from preclinical to clinic. Currently advancing single-gene edited UCART for solid tumours.

Agenda Sessions

  • Achieving Potent and Long-Term Persistence of Allogeneic CAR-T Cells through Glycosylation Manipulation

    , 11:10
    View Session

At this event

Prev
Next
Ivan Lin
Head of Manufacturing & Head of Global MSAT
JW Therapeutics

See Feifei at Cell & Gene Therapy Summit At ChinaBio Partnering Forum

Book Now